% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • qdelfan qdelfan Jan 5, 2013 4:32 PM Flag

    JP Morgan investor conference presentation on Monday

    Another opportunity for the company to turn around investor sentiment for it's stock on Monday. Anyone care to speculate on the message to be delivered? I hope they might have a press release prior to Monday morning's presentation in S.F. that might give some new data on cohort 3 of the VX 809/770 CF study and the official dates of initiation of the Phase 3 809/770 clinical trials and the timeline for it's completion and hopeful submission of a NDA for 809/770 treatment of the homozygous d508 CF population.

    Also perhaps, a release of clinical trial results of VX 787 to treat influenza (certainly timely given the news today about the severity of this year's influenza outbreak in the U.S.), with the possbility of it's clinical approval path to be outlined, (with or without a partnership with another large Pharma to underwrite the development costs and provide a upfront payment to keep revenues more in line with expenditures this year),

    Lastly, a coherent, upbeat and optimistic presentation on the rest of the Vertex pipeline including a timeline for completion of the expanded Kalydeco Phase 3 monotherapy clinical trials underway, and the expected date of submission for the expanded label to treat up to 15% of the CF population with Kalydeco alone. Also, the expected date of release of results of the trial using VX 661 in ascending doses to treat homozygous d508 CF patients with Kalydeco and the timing for the release of VX 509 data in RA and the initiation of trials using it in other autoimmune diseases (e.g. psoriasis, inflammatory bowel disease, etc). Lastly, the initiation of trials using VX 135 in all oral treatment combinations to cure hep C. Here's hoping Vertex management will make good use of this forum to start the New Year off with renewed confidence in the company's growth story.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
78.71+4.90(+6.23%)Oct 25 4:00 PMEDT